Publication date: Sep 06, 2019
Many neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease, are associated with microvascular dysfunction, but the cellular and molecular mechanisms are poorly understood. Recently, microRNAs (miRNAs) have been suggested to be involved in the microvascular dysfunction and subsequent memory impairment. MicroRNA-124 (miR-124) is one of the most abundant miRNAs in the brain that is dysregulated in the hippocampus of AD animals. To explore the role of miR-124 in AD pathology, we employed the APP/PS1 transgenic mice and found downregulation of miR-124 and upregulation of complement C1q-like protein 3 (C1ql3) in the hippocampus and cerebral cortex. Downregulation of miR-124 expression resulted in Aβ deposition and a variety of cerebromicrovascular impairments, including the decline in microvascular density, reduced angiogenesis, accompanied by C1ql3 alteration. Treatment with lentivirus-mediated overexpression of miR-124 or the C1q inhibitor C1INH rescued breakdown of blood-brain barrier, promoted angiogenesis and reduced Aβ deposition, and finally alleviated learning and memory deficit in APP/PS1 mice. Moreover, we found that C1ql3, a component of the classical complement, might be a potential target of miR-124. These results suggested that miR-124 was involved in the angiogenesis and vascular integrity in the hippocampus and the cerebral cortex of the AD mice by regulating the classical complement C1ql3.
Li, A.D., Tong, L., Xu, N., Ye, Y., Nie, P.Y., Wang, Z.Y., and Ji, L.L. miR-124 regulates cerebromicrovascular function in APP/PS1 transgenic mice via C1ql3. 22229. 2019 Brain Res Bull.
- MicroRNA-124 Enhances Dopamine Receptor Expression and Neuronal Proliferation in Mouse Models of Parkinson’s Disease via the Hedgehog Signaling Pathway by Targeting EDN2.
- MicroRNAs: Game Changers in the Regulation of α-Synuclein in Parkinson’s Disease.
- Preliminary study of hsa-miR-626 change in the cerebrospinal fluid of Parkinson’s disease patients.